How should vitamin D2 (ergocalciferol) be dosed to treat deficiency in adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Vitamin D2 (Ergocalciferol) Dosing for Deficiency Treatment

For adults with vitamin D deficiency, treat with 50,000 IU of ergocalciferol once weekly for 8 weeks (or 6,000 IU daily as equivalent), followed by maintenance therapy of 1,500-2,000 IU daily. 1

Treatment Regimens by Age Group

Adults (≥19 years)

  • Repletion phase: 50,000 IU weekly for 8 weeks OR 6,000 IU daily 1
  • Maintenance phase: 1,500-2,000 IU daily 1
  • Target: Achieve 25(OH)D level >30 ng/mL

The Endocrine Society guideline explicitly states that vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol) are both acceptable for treating deficiency 1. While recent research suggests vitamin D3 may be more potent at raising total 25(OH)D levels (mean difference of 15.69 nmol/L higher) 2, the guideline-recommended dosing accounts for this difference and remains clinically effective.

Children and Adolescents (1-18 years)

  • Repletion phase: 2,000 IU daily for at least 6 weeks OR 50,000 IU weekly for at least 6 weeks 1
  • Maintenance phase: 600-1,000 IU daily 1
  • Target: Achieve 25(OH)D level >30 ng/mL

Infants and Toddlers (0-1 year)

  • Repletion phase: 2,000 IU daily for 6 weeks OR 50,000 IU weekly for 6 weeks 1
  • Maintenance phase: 400-1,000 IU daily 1
  • Critical caveat: Avoid single doses exceeding 300,000 IU due to hypercalcemia risk 1

Special Populations Requiring Higher Doses

Obesity, Malabsorption, or Drug Interactions

These patients require 2-3 times the standard dose 1:

  • Repletion phase: 6,000-10,000 IU daily (at least)
  • Maintenance phase: 3,000-6,000 IU daily 1

This applies to patients on:

  • Anticonvulsant medications
  • Glucocorticoids
  • Antifungals (ketoconazole)
  • AIDS medications 1

Research confirms obese patients require substantially more vitamin D to achieve the same serum 25(OH)D increase 1. Body mass index >30 kg/m² increases risk of persistent deficiency by 2.5-fold even with treatment 3.

Pregnant and Lactating Women

  • Minimum: 600 IU daily
  • To maintain 25(OH)D >30 ng/mL: 1,500-2,000 IU daily 1

Practical Implementation Details

Dosing Flexibility

Ergocalciferol can be administered:

  • Daily
  • Weekly
  • Three times yearly 1

All schedules effectively maintain 25(OH)D levels. Weekly dosing (50,000 IU) improves compliance compared to daily regimens and is the most commonly prescribed approach 4.

Absorption Considerations

  • No food required: Ergocalciferol does not require dietary fat for absorption 1
  • Can be taken on empty stomach or with meals 1

Expected Response

  • Rate of increase: Approximately 0.4 ng/mL per 100 IU daily 1
  • Example: A patient with 25(OH)D of 15 ng/mL needs approximately 1,500 IU daily to reach 30 ng/mL 1
  • Research shows 50,000 IU weekly for 8 weeks increases mean 25(OH)D from 17.7 to 32.9 ng/mL 5

Monitoring and Safety

When to Monitor

  • Baseline: 25(OH)D and calcium levels
  • Follow-up: 60-180 days after initiating treatment 5
  • Special populations: Serial monitoring of 25(OH)D and calcium in patients with extrarenal production of 1,25(OH)₂D 1

Safety Thresholds

Upper tolerable limits without medical supervision 1:

  • Infants 0-6 months: 1,000 IU/day
  • Infants 6-12 months: 1,500 IU/day
  • Children 1-3 years: 2,500 IU/day
  • Children 4-8 years: 3,000 IU/day
  • Everyone >8 years: 4,000 IU/day

For deficiency correction, higher doses are safe 1:

  • Children 0-1 year: up to 2,000 IU/day
  • Children 1-18 years: up to 4,000 IU/day
  • Adults ≥19 years: up to 10,000 IU/day

Research confirms no toxicity with regimens totaling 600,000 IU over 60 days 4, and single doses of 300,000-600,000 IU cholecalciferol are safe 6.

Common Pitfalls

Inadequate Dosing

Standard regimens of 50,000 IU monthly achieve sufficiency in only 42% of patients 4. Weekly dosing is superior to monthly dosing for achieving target levels.

Non-Response

If 25(OH)D fails to increase after 8 weeks of treatment, evaluate for:

  • Non-compliance
  • Celiac disease
  • Cystic fibrosis
  • Severe malabsorption 1

Primary Hyperparathyroidism

Patients with primary hyperparathyroidism and vitamin D deficiency should receive treatment as needed, but monitor serum calcium closely 1.

Hypercalcemia Risk

Monitor calcium levels in patients with:

  • Williams syndrome
  • Conditions predisposing to hypercalcemia 1
  • Extrarenal production of 1,25(OH)₂D 1

Vitamin D2 vs D3 Considerations

While both forms are acceptable 1, recent evidence shows vitamin D3 is more effective at raising total 25(OH)D levels 2. One study demonstrated vitamin D3 (500,000 IU over 10 days) increased 25(OH)D by 47 ng/mL versus only 10 ng/mL with vitamin D2 (600,000 IU single dose) 7. Additionally, high-dose vitamin D2 may decrease 25(OH)D3 levels 7.

However, ergocalciferol remains widely used due to lower cost and availability 8, and the guideline-recommended doses account for these differences in potency.

References

4
Research

Evaluation of vitamin D repletion regimens to correct vitamin D status in adults.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2009

Related Questions

Why is high-dose vitamin D2 (ergocalciferol) prescribed instead of vitamin D3 (cholecalciferol)?
At what minimum age can ergocalciferol 50,000 IU be started for treating vitamin D deficiency?
In a patient with vitamin D deficiency, which is preferred—ergocalciferol (vitamin D₂) or cholecalciferol (vitamin D₃)—and what are the recommended repletion and maintenance dosing regimens?
What are the recommended ergocalciferol (vitamin D₂) dosing regimens for correcting deficiency in adults, including loading and maintenance doses, and how should dosing be adjusted for severe deficiency, chronic kidney disease, and pediatric patients?
Is it appropriate to prescribe ergocalciferol (vitamin D₂) 50,000 IU weekly followed by cholecalciferol (vitamin D₃) 1,000 IU daily for maintenance?
What is the clinical significance of the half‑life of testicular serum tumor markers (alpha‑fetoprotein, beta‑human chorionic gonadotropin, lactate dehydrogenase) for monitoring patients after orchiectomy or chemotherapy?
In a 50‑year‑old woman with a clear, mucous‑like, odorless vaginal discharge and labial irritation, what is the most likely cause?
What is the recommended anti‑tuberculosis therapy (ATT) regimen and dosing for children, including weight‑based doses and treatment duration?
What topical therapy is recommended for a methotrexate‑induced papular eruption superimposed on morphea?
Can misoprostol be taken with food without reducing its efficacy?
What is the recommended interval between misoprostol and levothyroxine administration?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.